Skip to main content

Table 2 Adjusted differences (receiving biologics or not) of individual annual healthcare costs and production value (Euros, 2016 prices)

From: The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study

Years from diagnosis

Outpatient visits

Hospital admissions

Primary sector

Production value

CD

UC

CD

UC

CD

UC

CD

UC

-10

111

145*

96

249

12

33*

345

-1380

-9

64

71

118

88

23

28*

740

-1142

-8

22

9

49

142

21

37*

214

-1989*

-7

32

43

26

-14

8

31*

-390

-655

-6

17

34

69

89

15

33*

0

-890

-5

15

28

23

42

14

24*

488

-1426

-4

72

-150*

86

2

26

16

473

-149

-3

71

-278*

285*

17

28*

13

538

48

-2

-53

-395*

193

-170

39*

9

547

76

-1

-164

-619*

457*

70

29*

13

1419*

393

1

-6711*

-4914*

-367

-2908*

6

-7

3611*

3460*

2

-7698*

-4859*

-1133*

-1962*

-7

3

3451*

3810*

3

-7127*

-4203*

-1259*

-1618*

-4

-8

3609*

2887*

4

-7060*

-4089*

-1293*

-1507*

11

-2

3713*

3077*

5

-6662*

-4171*

-1289*

-1041*

-16

2

4592*

2802*

6

-6883*

-3637*

-1167*

-962*

-8

-1

5184*

1831*

7

-5751*

-3171*

-1462*

-1249*

-9

-4

4483*

2322*

8

-5689*

-2768*

-1440*

-621*

3

8

5127*

2858*

9

-4981*

-2959*

-1651*

-717*

14

13

6618*

2358*

10

-4976*

-3077*

-1169*

-695*

-6

-2

6491*

2835*

11

-4806*

-3347*

-1807*

-1629*

-28

4

6412*

3735*

12

-4721*

-3086*

-1730*

-1161*

-20

-2

6366*

3443

13

-5183*

-1848*

-2015*

-832

-30

-28

7050*

2425

  1. *p ≤ 0.05